ATE213163T1 - Verfahren zur behandlung von motorischen defiziten - Google Patents

Verfahren zur behandlung von motorischen defiziten

Info

Publication number
ATE213163T1
ATE213163T1 AT96908801T AT96908801T ATE213163T1 AT E213163 T1 ATE213163 T1 AT E213163T1 AT 96908801 T AT96908801 T AT 96908801T AT 96908801 T AT96908801 T AT 96908801T AT E213163 T1 ATE213163 T1 AT E213163T1
Authority
AT
Austria
Prior art keywords
motor deficit
treating motor
treating
deficit
deficit symptoms
Prior art date
Application number
AT96908801T
Other languages
English (en)
Inventor
John Mcmichael
Original Assignee
Milkhaus Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milkhaus Lab Inc filed Critical Milkhaus Lab Inc
Application granted granted Critical
Publication of ATE213163T1 publication Critical patent/ATE213163T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Motors, Generators (AREA)
  • Processing Of Solid Wastes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96908801T 1995-04-13 1996-03-13 Verfahren zur behandlung von motorischen defiziten ATE213163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/421,231 US5576289A (en) 1995-04-13 1995-04-13 Methods for treating motor deficits
PCT/US1996/003456 WO1996032125A1 (en) 1995-04-13 1996-03-13 Methods for treating motor deficits

Publications (1)

Publication Number Publication Date
ATE213163T1 true ATE213163T1 (de) 2002-02-15

Family

ID=23669709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96908801T ATE213163T1 (de) 1995-04-13 1996-03-13 Verfahren zur behandlung von motorischen defiziten

Country Status (8)

Country Link
US (1) US5576289A (de)
EP (1) EP0769957B1 (de)
JP (1) JP2885517B2 (de)
AT (1) ATE213163T1 (de)
AU (1) AU686051B2 (de)
CA (1) CA2192675C (de)
DE (1) DE69619187T2 (de)
WO (1) WO1996032125A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
AU2004206971B8 (en) * 1997-03-04 2010-10-07 Milkhaus Laboratory, Inc. Method of treatment of conditions by administration of streptolysin O
US6998121B2 (en) * 2003-01-23 2006-02-14 Milkhaus Laboratory, Inc. Method of treatment of connective tissue disorders by administration of streptolysin O
US5736508A (en) * 1997-03-04 1998-04-07 Milkhaus Laboratory, Inc. Methods for treatment of scar tissue
US6303127B1 (en) 1997-03-04 2001-10-16 Milkhaus Laboratory, Inc. Treatment of disease states
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
US20100144602A1 (en) * 2003-01-23 2010-06-10 Milkhaus Laboratory, Inc. Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O
US7629312B2 (en) 2003-01-23 2009-12-08 Milkhaus Laboratory, Inc. Method of treatment of tendonitis by administration of streptolysin O
WO2008094379A2 (en) * 2007-01-30 2008-08-07 Milkhaus Laboratory, Inc. Methods for treatment of pulmonary fibrosis
WO2012158216A1 (en) 2011-05-16 2012-11-22 Beech Tree Labs, Inc. Methods of treating a disorder associated with sequestered bacteria
AU2013226216B2 (en) 2012-02-27 2016-04-07 Beech Tree Labs, Inc. Method of treating chronic obstructive pulmonary disease
JP2018510895A (ja) 2015-04-08 2018-04-19 ビーチ ツリー ラボ、インコーポレイテッド 外傷性脳損傷を治療する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1582692A (en) * 1991-03-08 1992-10-06 Protein Design Labs, Inc. Recombinant double chain immunotoxins
US5378620A (en) * 1991-08-30 1995-01-03 Beckman Instruments, Inc. Streptolysin O derivatives
DE4240056A1 (de) * 1992-11-28 1994-06-01 Boehringer Mannheim Gmbh Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper
AU6098194A (en) * 1993-01-29 1994-08-15 Ariad Pharmaceuticals, Inc. Analogs of receptor tyrosine activation motifs and therapeutic uses thereof

Also Published As

Publication number Publication date
DE69619187T2 (de) 2002-10-31
CA2192675A1 (en) 1996-10-17
JP2885517B2 (ja) 1999-04-26
EP0769957A4 (de) 1999-11-03
WO1996032125A1 (en) 1996-10-17
AU5252196A (en) 1996-10-30
CA2192675C (en) 2002-05-28
EP0769957B1 (de) 2002-02-13
US5576289A (en) 1996-11-19
AU686051B2 (en) 1998-01-29
EP0769957A1 (de) 1997-05-02
JPH09509968A (ja) 1997-10-07
DE69619187D1 (de) 2002-03-21

Similar Documents

Publication Publication Date Title
ATE266417T1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
DE60027732D1 (de) Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69008820T2 (de) Verfahren zur Behandlung von Polymerisaten.
DE69710422T2 (de) Verfahren zur Behandlung von Polyethern vor Hydrosilylation
DE69637593D1 (de) Arteriovenöse und venöse transplantatbehandlungen: methoden und zusammensetzungen
ATE320803T1 (de) Verfahren zur behandlung von alzheimerschen krankheit
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
ATE213163T1 (de) Verfahren zur behandlung von motorischen defiziten
DE69519213D1 (de) Verfahren zur Behandlung von Kunststoff-,Leder- oder Kautschuksubstraten
DE69129460D1 (de) Verwendung von Anti-ICAM Antikörpern zur Herstellung eines Präparats für die BEHANDLUNG VON ENDOTOXINSCHOCK
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE484294T1 (de) Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE59102745D1 (de) Verfahren une einrichtung zur behandlung von saatgut.
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
DE69102294T2 (de) Verfahren zur Behandlung von Abgasen, die ClF3 enthalten.
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE58902128D1 (de) Verfahren zur behandlung von klaerschlamm.
DE69105823T2 (de) Verfahren zur Behandlung von Metallmatrixverbundwerkstoffen.
DE69006509D1 (de) Verfahren zur behandlung von häuten.
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties